COVID-19 Spike Protein (Alpha Variant) mRNA-LNP
This product utilizes the lipid nanoparticle (LNP) technology platform for The spike protein of COVID-19 is a glycoprotein that helps the virus attach to various surfaces in the built environment, increasing the potential for virus transmission. The best-known vaccines we use are the spike protein vaccines delivered via mRNA. While the role of vaccination in controlling outbreaks is undeniable, the recurring emergence of new variants of Covid-19, such as the Delta and Omega variants, poses new challenges, particularly their rapid global spread.
This product is designed as a tool for the delivery and expression of full-length spike protein mRNA of COVID-19 Strain Alpha for vaccine research.
This product utilizes the lipid nanoparticle (LNP) technology platform for simple and efficient delivery of the Alpha variant spike protein (COVID-19) mRNA to a variety of mammalian cells in vitro and in vivo. The LNP’s used are formulated with, SM-102, DSPC, cholesterol, and DMG-PEG2000 at optimal molar concentration for a high rate of encapsulation and efficient mRNA delivery. Alpha Spike protein consists of 1273 amino acids and its GenPept accession number is YP_009724390.